Frequencies and percentages were computed for categorical variables such as gestational age, mode of delivery, risk factors of perinatal deaths in preceding pregnancy, risk factor of perinatal deaths in present pregnancy and recurrence risk
We present the results of the cross-country growth regressions in Table 2 for the baseline model and in Table 3 for the model with the alternative definition of conflict recurrence risk
, which is discussed in detail in assessing the robustness of the results.
4 GBq) according to their ATA recurrence risk
stratification [sup] within 3 months after surgery; they underwent levothyroxine (LT4) withdrawal or no replacement treatment and a low-iodine diet for at least 2-6 weeks when serum TSH levels were >30 [micro]IU/ml.
discussion of recurrence risk
and risk reduction for the couple and close family.
If the child with primary autism was found to have a genetic cause for his condition, such as a CNV that is not present in either parent, a low recurrence risk
, on the order of 1%, can be cited.
The new tool--called the Recurrence Risk
Estimator at 90 Days score (RRE-90 score)--is based on a calculation involving risk factors that can be identified in the emergency room, according to a report published Jan.
The only significant predictor of increased recurrence risk
was prostatic involvement.
An ongoing randomised controlled trial is examining whether or not the increased local recurrence risk
of focally positive or close margins can be counterbalanced by increasing the boost dose, since further re-excision surgery is often technically difficult and it is seldom that any residual tumour is found in the re-excision specimen.
Taxane-based therapy in women younger than age 50 conferred a 16% reduction in recurrence risk
, compared with anthracycline-based regimens, and a 14% reduction in breast cancer mortality through the first 4 years of follow-up.
Steps down the slippery slope to adoption without proper demonstration of utility can already be seen with tests purporting to identify those individuals of sufficiently low recurrence risk
that particular adjuvant therapies (predominantly chemotherapy) may be avoided completely.
The treatment begins after final pathologic evaluation of margins, lymph nodes and other features that have an impact on recurrence risk
A genetic evaluation will help define the prognosis, aid in management decisions, define accurate recurrence risk
for the parents, and permit access to appropriate support groups.